Evidence map›Paper›PMID 15371157›Full record

ReviewJournal of neurovirology2004

Mapping herpes simplex virus type 1 latency-associated transcript sequences that protect from apoptosis mediated by a plasmid expressing caspase-8.

W Peng, L Jin, G Henderson, G C Perng, D J Brick, A B Nesburn, S L Wechsler, C Jones

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neurovirology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Infectious agents and neurodegeneration.Molecular neurobiology · 2012
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

W PengDepartment of Veterinary and Biomedical Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln 68583-0905, USA.
L Jin
G Henderson
G C Perng
D J Brick
A B Nesburn
S L Wechsler
C Jones
University of California, Irvine · USUniversity of Nebraska–Lincoln · US

Funding

VIRAL SHUTOFF OF HOST TRANSCRIPTION--PBCV-1 INFECTEDP20RR015635 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI ZHENG, JIALIN CHARLES · 2000 to 2009
$22.1M
Corneal HSV-1: LAT's Anti-Apoptosis Activity and LatencyR01EY013191 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI WECHSLER, STEVEN L · 2001 to 2013
$6.9M
CORNEAL HSV-1: A NOVEL VIRULENCE/REACTIVATION GENER01EY012823 · NEI · UNIVERSITY OF CALIFORNIA IRVINE · PI WECHSLER, STEVEN L · 2000 to 2004
$2.4M
NCRR NIH HHS 1P20RR15635NEI NIH HHS EY12823NEI NIH HHS EY13191
6 · The paper itself

Abstract

LAT (latency-associated transcript) is the only herpes simplex virus type 1 (HSV-1) transcript abundantly expressed during neuronal latency. LAT expression is required for the high reactivation phenotype of HSV-1 and this phenotype correlates with LAT's anti-apoptosis properties. LAT nucleotides 1 to 1499 inhibit caspase-8 (death receptor apoptotic pathway), but not caspase-9 (mitochondrial apoptotic pathway), -induced apoptosis as efficiently as larger LAT fragments. LAT sequences important for inhibiting caspase-8-induced apoptosis were also localized. The ability of LAT nucleotides 1 to 1499 to efficiently inhibit caspase-8-induced apoptosis correlates with the high reactivation phenotype of a mutant virus expressing just the first 1.5 kb of LAT (nucleotides 1 to 1499).

Indexed as

ApoptosisTranscription, GeneticAnimalsCaspase 8CaspasesHerpesvirus 1, HumanHumansPlasmidsT-LymphocytesVirus LatencyCASP8 protein, humanCaspase 8Caspases

Identifiers

PMID15371157
OpenAlexW2047847499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.